Niklas Sarelin, Valtteri Kairaluoma, Juha Saarnio, Joonas H Kauppila, Jan Böhm, Heikki Huhta, Olli Helminen, Juha P Väyrynen
{"title":"Tumour necrosis as a prognostic indicator in hepatocellular carcinoma.","authors":"Niklas Sarelin, Valtteri Kairaluoma, Juha Saarnio, Joonas H Kauppila, Jan Böhm, Heikki Huhta, Olli Helminen, Juha P Väyrynen","doi":"10.1186/s12885-026-16040-z","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9131,"journal":{"name":"BMC Cancer","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2026-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12885-026-16040-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
BMC Cancer is an open access, peer-reviewed journal that considers articles on all aspects of cancer research, including the pathophysiology, prevention, diagnosis and treatment of cancers. The journal welcomes submissions concerning molecular and cellular biology, genetics, epidemiology, and clinical trials.